Biofeedback Training on Shoulder Muscles Strength Post Mastectomy

July 31, 2024 updated by: Nourhan Ahmed Mahmoud Souliman, Cairo University

PURPOSE:The purpose of the study is to evaluate the effect of biofeedback on shoulder muscles strength post mastectomy.

BACKGROUND:

  • The most common complications following mastectomy are pain, ipsilateral lymphedema of the upper limb (UL), reduced range of motion (ROM) of the shoulder, flexion and abduction is limited to 90°, and external rotation is limited to 40°, and there are postural changes
  • One of the most common complications after breast cancer surgery is a functional limitation of the upper body. Up to 67% of breast cancer patients experience arm or shoulder impairment, including pain, numbness, loss of strength, and reduced ROM, after surgery
  • Shoulder problems in breast cancer patients affect their daily activities, such as pulling a sweater overhead, fastening a bra, zipping up a back zipper, reaching overhead, and carrying heavy bags.
  • Biofeedback is a mind-body technique in which individuals learn how to modify their physiology for the purpose of improving physical, mental, emotional and spiritual health. Much like physical therapy, biofeedback training requires active participation on the part of patients and often regular practice between training sessions. Clinical biofeedback may be used to manage disease symptoms as well as to improve overall health and wellness through stress management training. Research has shown that biofeedback interventions are efficacious in treating a variety of medical conditions, and many Americans are turning to biofeedback and other less traditional therapies for their (Dana et al., 2010).

HYPOTHESES: null hypothesis

RESEARCH QUESTION: Does biofeedback give effect on shoulder muscles strength post mastectomy?

Study Overview

Detailed Description

27 patient per group to G power 90% a Inclusion Criteria:

The subject selection will be according to the following criteria:

  • Female patients with age range between 40-60 will participate in the study.
  • All patients with their informed consent.
  • All patients with unilateral mastectomy
  • All patients have shoulder muscle weakness within 2 to 4 months post mastectomy
  • All patients with chemo or radio therapy 1.2.b Exclusion Criteria:

The potential participants will be excluded if they meet one of the following criteria:

  • metastasis
  • Psychological Disorder
  • Lymphedema
  • Neurological or musculoskeletal disorders

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 02
        • Nourhan Ahmed mahmoud souliman
    • Bahyea Foundation For Breast Cancer
      • Cairo, Bahyea Foundation For Breast Cancer, Egypt, 02
        • Nourhan Souliman

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • The subject selection will be according to the following criteria:
  • Female patients with age range between 40-60 will participate in the study.
  • All patients with their informed consent.
  • All patients with unilateral mastectomy
  • All patients have shoulder muscle weakness within 2 to 4 months post mastectomy
  • All patients with chemo or radio therapy

Exclusion Criteria:

  • The potential participants will be excluded if they meet one of the following criteria:
  • metastasis
  • Psychological Disorder
  • Lymphedema
  • Neurological or musculoskeletal disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Affected arm at the same side of mastectomy
There is 2 arms Arm1:-arm at side of mastectomy without lymphedema trained by biofeedback
Intervention 1 :-Using the biofeedback device with dumble to strength affected arm post mastectomy
Other Names:
  • Expirmental trial by biofeedback device
Shoulder mobilization Shoulder ladder ex Shoulder wheel ex Ipc
Other Names:
  • Intervention 2 :- using traditional PT programme without using biofeedback
Experimental: 2 arms one trained by biofeedback and other control without biofeedback
Arm2:-arm at side of mastectomy on other group but not trained with biofeedback Training using shoulder ladder ,shoulder wheel ,shoulder mobilization and IPC
Shoulder mobilization Shoulder ladder ex Shoulder wheel ex Ipc
Other Names:
  • Intervention 2 :- using traditional PT programme without using biofeedback

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure before and after shoulder muscles strength by hand held dynamometer
Time Frame: 6 wweks
Measuring
6 wweks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Research ethical commity Physical therapy Cairo university, Research ethical commity

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2023

Primary Completion (Actual)

May 5, 2024

Study Completion (Actual)

May 9, 2024

Study Registration Dates

First Submitted

January 14, 2024

First Submitted That Met QC Criteria

January 18, 2024

First Posted (Actual)

January 26, 2024

Study Record Updates

Last Update Posted (Actual)

August 2, 2024

Last Update Submitted That Met QC Criteria

July 31, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • P.T.REC/012/004823
  • 202309250044 (Registry Identifier: Baheya research center)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe